<DOC>
	<DOC>NCT02547727</DOC>
	<brief_summary>A four-site intradermal rabies booster vaccination in HIV - infected patients who have ever received primary rabies vaccination could improve their immune response to this kind of vaccine.</brief_summary>
	<brief_title>Immune Responses After a Four-site Intradermal Rabies Booster Vaccination in HIV-infected Adults</brief_title>
	<detailed_description>A four-site intradermal rabies booster vaccination has shown higher immune response than conventional intramuscular rabies booster vaccination in healthy persons. So, the investigators hypothesized the same outcome in HIV - infected patients.</detailed_description>
	<mesh_term>Rabies</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>HIV infected patients Age 18 60 years Received primary rabies immunization Have any active opportunistic infections Received blood or blood product within 3 months Allergy to vaccine or any vaccine components Received antimalarial drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>rabies vaccination</keyword>
</DOC>